| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
19,435
|
19,516
|
17,876
|
49,758
| | Cost of Revenue | 3,291 | 3,017 | 2,635 | 4,014 | | |
Gross Profit
|
16,145
|
16,499
|
15,241
|
45,744
| |
|
Operating Expenses |
|
Research Development | 9,886 | 11,867 | 10,710 | 11,557 |
|
Selling General and Administrative | 37,750 | 34,952 | 30,802 | 33,859 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(31,491)
|
(30,320)
|
(26,272)
|
328
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 159 | 31,321 | 196 | 44 |
|
Earnings Before Interest And Taxes | (31,332) | 1,001 | (26,076) | 373 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (31,332) | 1,001 | (26,076) | 373 |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (31,332) | 1,001 | (26,771) | (296) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(31,332)
|
1,001
|
(26,771)
|
(296)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(31,332)
|
1,001
|
(26,771)
|
(296)
|
|